BDMD
Baird Medical Investment Holdings Limited
NASDAQ: BDMD · HEALTHCARE · MEDICAL DEVICES
$1.72
+0.58% today
Updated 2026-04-30
Market cap
$67.58M
P/E ratio
—
P/S ratio
3.00x
EPS (TTM)
$-0.11
Dividend yield
—
52W range
$1 – $7
Volume
1.5M
Baird Medical Investment Holdings Limited (BDMD) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $12.21M | $18.12M | $27.72M | $35.09M | $31.46M | $37.04M | $22.54M |
| Revenue growth (YoY) | — | +48.4% | +53.0% | +26.6% | -10.4% | +17.7% | -39.2% |
| Cost of revenue | $1.30M | $2.51M | $4.54M | $7.05M | $4.23M | $4.38M | $3.65M |
| Gross profit | $10.91M | $15.61M | $23.18M | $28.04M | $27.23M | $32.65M | $18.88M |
| Gross margin | 89.4% | 86.1% | 83.6% | 79.9% | 86.6% | 88.2% | 83.8% |
| R&D | $1.16M | $750482.00 | $1.04M | $3.86M | $4.27M | $6.17M | $20.13M |
| SG&A | $1.10M | $1.76M | $6.65M | $6.96M | $8.55M | $5.90M | $14.12M |
| Operating income | $5.61M | $9.86M | $11.92M | $13.63M | $11.86M | $15.32M | $-25.54M |
| Operating margin | 45.9% | 54.4% | 43.0% | 38.8% | 37.7% | 41.4% | -113.3% |
| EBITDA | $5.85M | $10.28M | $14.16M | $16.29M | $12.88M | $16.17M | $-24.53M |
| EBITDA margin | 47.9% | 56.7% | 51.1% | 46.4% | 40.9% | 43.7% | -108.9% |
| EBIT | $5.50M | $9.67M | $12.76M | $14.82M | $11.86M | $14.66M | $-25.64M |
| Interest expense | $89617.00 | $159471.00 | $153921.00 | $299269.00 | $284271.00 | $576752.00 | $737370.00 |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-7.18M | $7.10M | $11.68M | $12.57M | $10.55M | $12.45M | $-27.28M |
| Net income growth (YoY) | — | +198.8% | +64.5% | +7.6% | -16.1% | +18.1% | -319.0% |
| Profit margin | -58.8% | 39.2% | 42.1% | 35.8% | 33.5% | 33.6% | -121.0% |